Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients
중환자 COVID-19 환자의 폐 응고 촉진제 및 선천성 면역 반응
Clinical Trial
[키워드] activated
Activation
acute respiratory distress
Antigen
Biomarker
bronchoalveolar
Bronchoalveolar lavage fluid
bronchoalveolar space
C1-Inhibitor
CD40 ligand
chemokine
Coagulation
complement
complexes
COVID-19
COVID-19 patient
Critically ill
Cytokines
declined
domain
evaluate
FIVE
Follow-up
functional
growth factor
Growth factors
healthy controls
host response
Ill
implicated
Inflammatory
Inflammatory response
inhibitor
Innate
innate immune response
Local
lung
measurement
mechanical ventilation
mechanism
objective
P-selectin
pathogenesis of COVID-19
pathway
Patient
patients
patients with COVID-19
persistent ARDS
plasma
plasma sample
procoagulant
pulmonary
rationale
response
Result
severe COVID-19
significantly increased
stratified
syndrome
systemic
tissue
type I
ventilated patient
were measured
with COVID-19
[DOI] 10.3389/fimmu.2021.664209 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.3389/fimmu.2021.664209 PMC 바로가기 [Article Type] Clinical Trial